Hypercholesterolemia

CHICAGO — When race was removed from the MESA risk prediction score, its ability to predict risk for heart disease did not change significantly, researchers reported at the American Heart Association Scientific Sessions.

BOSTON — In this Healio video exclusive, Erin D. Michos, MD, MHS, FAHA, FACC, FASE, FASPC, discusses her presentation at the Cardiometabolic Health Congress, “Primary Prevention of CVD: The Sooner the Better?”

Due to demographic changes and a rise in risk factors, the prevalence and economic burden of heart disease and stroke in the United States are expected to increase dramatically by 2050, according to the American Heart Association.

SAN FRANCISCO — An updated evidence-based guideline for the assessment and management of polycystic ovary syndrome includes new recommendations for a timelier diagnosis and evidence that firmly supports PCOS is a risk factor for CVD.

ATLANTA — A screening study presented at the American College of Cardiology Scientific Session showed that there is a high prevalence of unrecognized heart disease among former National Football League players.

A prespecified analysis of the CLEAR Outcomes trial shows that the benefits of bempedoic acid extend to patients with recurrent CV events, including a total reduction in MI risk of 31% vs. placebo.

Data from a real-world cohort in Italy show female sex is the only independent variable associated with lower probability of achieving LDL target level for every risk category, regardless of whether the patient is prescribed statin therapy.